SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: A prospective multicenter pharmacogenetics study of metastatic colorectal cancer
第一作者单位:[1]Tongji Hosp, Tongji Med Coll, Tongji Canc Ctr, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
Yuan X.,Huang L.,Zhang T.,et al.SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: A prospective multicenter pharmacogenetics study of metastatic colorectal cancer[J].EUROPEAN JOURNAL OF CANCER.2013,49:S563-S564.
APA:
Yuan, X.,Huang, L.,Zhang, T.,Xie, C. H.,Liao, X....&Qin, K..(2013).SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: A prospective multicenter pharmacogenetics study of metastatic colorectal cancer.EUROPEAN JOURNAL OF CANCER,49,
MLA:
Yuan, X.,et al."SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: A prospective multicenter pharmacogenetics study of metastatic colorectal cancer".EUROPEAN JOURNAL OF CANCER 49.(2013):S563-S564